Caregiver-Assisted Oral Fluid-based HIV Screening in Children: Zambia
NCT ID: NCT04754386
Last Updated: 2022-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2730 participants
OBSERVATIONAL
2021-02-08
2021-12-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Caregiver-Assisted Oral Fluid-based HIV Screening in Children: Uganda
NCT04774666
Integrating Enhanced HIV PrEP Into a STI Clinic in Lilongwe
NCT05307991
Secondary Distribution of HIV Self-tests Through Antenatal Care Clinic Attendees and Index Clients
NCT03705611
Acceptability and Performance of HIV Self-Testing in a Youth Population in Nigeria
NCT03874663
A Cluster Randomised Trial of Community-led Distribution of HIV Self-tests in Rural Malawi (HIV Self-Testing Africa [STAR])
NCT03541382
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: The study will have a cross-sectional cluster sampling design, in which large facilities in two provinces will be selected using probability-proportional-to-size (PPS) sampling. Within each of 15 selected facilities, adult index parent/caregivers who are the parent/caregivers of approximately 200 children will be recruited to accept oral fluid-based HIV test kits for their children. There will be 3000 participants in the sample. Index parent/caregivers will be consented to participate in the study, given a number of OTKs corresponding to the number of children eligible for testing, followed up to confirm saliva-based test (SBT) results, participate in a testing experience survey, and return the OTK. All children screening HIV-positive will receive active linkage to confirmatory diagnostic testing, and treatment services for newly diagnosed HIV-positive children. In addition to these data, a sample (n=445) of caregivers will be asked questions regarding their experiences with administering the screening kit on their children.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acceptability of OraQuick Advance© Rapid HIV-1/2 Antibody screening Oral fluid-based HIV test
The project offers HIV oral test kits to index parents/caregivers with children eligible for index testing services at facility settings to expand access to HIV testing and treatment services for children, and to ensure that all children who screen positive with an oral fluid-based HIV screening kit are linked to confirmatory testing, and newly diagnosed children are initiated on ART.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years old or older with eligible children
• All biological children (of an adult index case) 18 months - 14 years of age with an unknown HIV status
Exclusion Criteria
* Adults previously diagnosed as mentally disabled
* Adults currently in prison are excluded from this study.
* Adult partners of index parent/caregivers
* Children \<18 months of age
* All biological children (of an index case) 18 months - 14 years of age with a documented HIV-negative status after cessation of breastfeeding
* All biological children (of an index case) 18 months - 14 years of age with a documented HIV-positive status
* Children still breastfeeding or with cessation of breastfeeding \< 3 months
* Non-biological children of the index parent/caregiver
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centers for Disease Control and Prevention
FED
Catholic Relief Services
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carl C Stecker, MPH, EdD
Role: PRINCIPAL_INVESTIGATOR
Catholic Relief Services - USCCB
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mutendere Clinic
Mutendere, Lusaka Province, Zambia
Chitope Rural Health Centre
Mwavi, Lusaka Province, Zambia
Nadezwe Rural Health Center
Chikankata, Southern Province, Zambia
Chivuna Rural Health Centre
Livingstone, Southern Province, Zambia
Munenga Rural Health Centre
Mazabuka, Southern Province, Zambia
Keemba Rural Health Centre
Monze, Southern Province, Zambia
Manungu Rural Health Centre
Monze, Southern Province, Zambia
Chazanga Clinic
Lusaka, , Zambia
Chilanga Clinic
Lusaka, , Zambia
Chilenje Clinic
Lusaka, , Zambia
Kalingalinga Clinic
Lusaka, , Zambia
Kazimva Rural Health Clinic
Lusaka, , Zambia
Matero Clinic
Lusaka, , Zambia
Nan'gongwe Clinic
Lusaka, , Zambia
Shimabala Rural Health Centre
Lusaka, , Zambia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gross J, Tumwesigye NM, Mutembo S, Moyo N, Mukose A, Chilyabanyama O, Matoba J, Parris K, Lee B, Churchill T, Williamson D, Pals S, Biribawa C, Kagaayi J, Ndubani P, Okello F, Zyambo Z, Taasi G, Magongo EN, Munthali G, Mwiya M, Nazziwa E, Awor AC, Itoh M, Boyd AM, Macleod D, Rivadeneira E, Oliver D, Ferrand RA, Stecker C; FASTER Study Team. Acceptability, feasibility, and effectiveness of caregiver-assisted HIV self-testing among children using an oral mucosal test in Uganda and Zambia: a prospective interventional study. Lancet HIV. 2025 May;12(5):e325-e337. doi: 10.1016/S2352-3018(25)00005-0.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDC IRB 7272
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.